Trials / Completed
CompletedNCT00919737
Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme
A Phase 1/2, Multicenter, Non-Randomized, Open Label Clinical Trial of NPC-08 Implant in Patients Undergoing Surgery for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme.
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Nobelpharma · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether NPC-08 is safety and efficacy in the treatment of newly-diagnosed malignant glioma and recurrent glioblastoma multiforme.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NPC-08 | Polifeprosan 20 with Carmustine 3.85% |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2009-06-12
- Last updated
- 2013-10-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00919737. Inclusion in this directory is not an endorsement.